Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - Other
Ratios

Aclaris Therapeutics (ACRS) Receivables - Other (2017 - 2021)

Aclaris Therapeutics (ACRS) has 4 years of Receivables - Other data on record, last reported at $24000.0 in Q4 2021.

  • For Q4 2021, Receivables - Other fell 92.0% year-over-year to $24000.0; the TTM value through Dec 2021 reached $24000.0, down 92.0%, while the annual FY2021 figure was $24000.0, 92.0% down from the prior year.
  • Receivables - Other reached $24000.0 in Q4 2021 per ACRS's latest filing, roughly flat from $24000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $300000.0 in Q2 2020 and bottomed at -$570000.0 in Q4 2017.
  • Average Receivables - Other over 4 years is $56166.7, with a median of $24000.0 recorded in 2021.
  • Peak YoY movement for Receivables - Other: surged 200.0% in 2020, then plummeted 92.0% in 2021.
  • A 4-year view of Receivables - Other shows it stood at -$570000.0 in 2017, then surged by 117.54% to $100000.0 in 2019, then soared by 200.0% to $300000.0 in 2020, then tumbled by 92.0% to $24000.0 in 2021.
  • Per Business Quant database, its latest 3 readings for Receivables - Other were $24000.0 in Q4 2021, $24000.0 in Q2 2021, and $20000.0 in Q1 2021.